Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Foot-skin Microbiome and Metabolomics in Pitted Keratolysis
NCT04781036Active, not recruiting
- Sponsor
- Mahidol University
- Start
- May 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of chlorhexidine in pitted keratolysis (PK) and bromodosis (3 arms), sponsored by Mahidol University. Primary endpoints: Amount of skin microbiome at 2 months and Composition of microbiota at skin at 2 months. Started May 2023; status: active, not recruiting.
02
Drugs
chlorhexidine
03
Conditions
pitted keratolysis (PK)bromodosis
Beyond the preview
Go deeper on NCT04781036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04781036.